Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DuPont Nutrition & Biosciences was a global leader in the specialty ingredients and bioscience markets, providing innovative solutions for the food, beverage, and pharmaceutical industries. The company was formed through the strategic combination of DuPont's nutrition assets with Danisco and Solae, focusing on high-growth areas like probiotics, enzymes, and plant-based proteins. In February 2021, the division completed a $26.2 billion merger with International Flavors & Fragrances (IFF) via a Reverse Morris Trust. This merger created a powerhouse in the global ingredients industry, with the legacy DuPont business now operating within IFF's Health & Biosciences and Nourish divisions. The company is particularly recognized for its extensive clinical research into the human microbiome and its large-scale fermentation capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DuPont Nutrition Biosciences.